Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Marta Carmona Campos"'
Autor:
Nieves Martínez-Lago, Soledad Cameselle García, Beatriz Alonso de Castro, Martín I. Gómez-Randulfe Rodríguez, Marta Carmona Campos, Paula González Villarroel, Mercedes Salgado Fernández, Juan C. De la Cámara Gómez, Carlos Romero Reinoso, Antía Cousillas Castiñeiras, José Carlos Méndez Méndez, Yolanda Vidal Insua, Ana Fernández-Montes
Publikováno v:
PLoS ONE, Vol 17, Iss 6 (2022)
Background The VELOUR study showed the benefit of FOLFIRI-Aflibercept (FA) versus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in second-line treatment. However, only 36% of the included patients were ≥65 years. Thus, we seek to eva
Externí odkaz:
https://doaj.org/article/e00901a0b5b7464ca871c78422a4ada3
Autor:
Nieves Martínez-Lago, Soledad Cameselle García, Beatriz Alonso de Castro, Martín I. Gómez-Randulfe Rodríguez, Marta Carmona Campos, Paula González Villarroel, Mercedes Salgado Fernández, Juan C. De la Cámara Gómez, Carlos Romero Reinoso, Antía Cousillas Castiñeiras, José Carlos Méndez Méndez, Yolanda Vidal Insua, Ana Fernández-Montes
Publikováno v:
PloS one. 17(6)
Background The VELOUR study showed the benefit of FOLFIRI-Aflibercept (FA) versus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in second-line treatment. However, only 36% of the included patients were ≥65 years. Thus, we seek to eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeaaf1c74f10bfe501df8239567e0e09
https://pubmed.ncbi.nlm.nih.gov/35657983
https://pubmed.ncbi.nlm.nih.gov/35657983
Autor:
Antia, Cousillas Castineiras, Elena, Gallardo Martin, Ana, Fernandez Montes, Marta, Carmona Campos, Marta, Covela Rua, Mercedes, Salgado Fernandez, María Luz, Pellon Augusto, Nieves, Martínez Lago, Yolanda, Vidal Insua, Elena, Brozos Vazquez, Juan, De La Camara, Ana, Alonso Herrero, Jose Carlos, Mendez Mendez
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(5)
The neutrophil-to-lymphocyte ratio (NLR) is an accessible marker from a routine blood test. This study explored the prognostic and predictive value of a change in NLR (c-NLR) after chemotherapy, baseline NLR (bNLR) and chemotherapy response, in metas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e877eaf1b27ee8fedecb2b7d2f8b4442
https://pubmed.ncbi.nlm.nih.gov/34761627
https://pubmed.ncbi.nlm.nih.gov/34761627
Autor:
Nieves Martinez Lago, Ana Fernández Montes, Marta Covela Rúa, Elena M. Brozos Vázquez, Juan C. De la Cámara Gómez, Jose C. Méndez Méndez, Mónica Jorge Fernández, Antía Cousillas Castiñeiras, Cristina Reboredo Rendo, David Arias Ron, Marta Carmona Campos, Yolanda Vidal Insua, Maria L. Pellón Augusto, Paula González Villarroel, Begoña Graña Suarez, Mercedes Salgado Fernández, Alberto Carral Maseda, Francisca Vázquez Rivera, Sonia Candamio Folgar, Margarita Reboredo López
Background Outcomes are poorer in metastatic colorectal cancer (mCRC) patients with BRAF V600E mutations than those without it, but the effect of these mutations on treatment response is unclear. This real-world study assessed the effects of antiangi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4516fdfd7ed86ceeb492a6f2d08d1f56
https://doi.org/10.21203/rs.3.rs-79440/v1
https://doi.org/10.21203/rs.3.rs-79440/v1
Autor:
Laura Arias, F.J. Afonso, Juan Ruiz Bañobre, Marta Carmona Campos, Jesús García Mata, Sergio Vázquez Estévez, Natalia Fernández Núñez, Rocio Vilchez Simo, Soledad Cameselle Garcia, Begoña Campos Balea, Manuel Constenla, J. L. Fírvida, Sara Agraso Busto, Noemi De Dios Alvarez, Joaquin Casal Rubio, Maria Carmen Areses Manrique, Diego Pereiro Corbacho
Publikováno v:
Journal of Clinical Oncology. 37:e20579-e20579
e20579 Background: The current treatment of advanced non-small cell lung cancer (NSCLC) is conditioned by the presence of molecular and immunohistochemical biomarkers. In the absence of these, the therapeutic option is the use of chemotherapy with or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5b97cd802d47af5013f54d4a0139d5d
https://doi.org/10.1200/jco.2019.37.15_suppl.e20579
https://doi.org/10.1200/jco.2019.37.15_suppl.e20579
Autor:
Carlos Méndez Méndez, Begoña Graña Suárez, Sonia Candamio Folgar, Guillermo Alfonso Quintero Aldana, Paula Gonzalez Villarroel, Marta Covela Rúa, Elena Brozos Vazquez, Carlos Grande Ventura, Juan de la Cámara Gómez, Alberto Carral Maseda, Francisca Vázquez Rivera, Mercedes Salgado Fernández, Mónica Jorge Fernández, Marta Carmona Campos, Margarita Reboredo Lopez, Antia Cousillas Castiñeira, Ana Montes, Elena Gallardo Martin, Nieves Martinez Lago, Maria Luz Pellon Augusto
Publikováno v:
Journal of Clinical Oncology. 37:620-620
620 Background: Activating B-type Raf kinase (BRAF) mutations, mostly missense V600E, occur in approximately 8% to 12% of patients with metastatic colorectal cancer (mCRC). BRAF (V600E)mt is a strong predictor of a poor prognosis, with distinct clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::623bf7a71c92469aef834ed576adf8f2
https://doi.org/10.1200/jco.2019.37.4_suppl.620
https://doi.org/10.1200/jco.2019.37.4_suppl.620
Autor:
Begoña Graña Suárez, Juan de la Cámara Gómez, Carlos Méndez Méndez, Elena Gallardo Martin, Nieves Martinez Lago, Maria Luz Pellon Augusto, Margarita Reboredo Lopez, Antia Cousillas Castiñeira, Sonia Candamio Folgar, Carlos Grande Ventura, Guillermo Alfonso Quintero Aldana, Paula Gonzalez Villarroel, Elena Brozos Vazquez, Mónica Jorge Fernández, Marta Covela Rúa, Ana Montes, Francisca Vázquez Rivera, Marta Carmona Campos, Mercedes Salgado Fernández, Alberto Carral Maseda
Publikováno v:
Journal of Clinical Oncology. 37:622-622
622 Background: Multiple studies have reported prognostic association of neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLT) and albumin levels including patients with early and advanced metastatic colorectal cancer. However, it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dca78e5125cb930a836192fbfd79fcbf
https://doi.org/10.1200/jco.2019.37.4_suppl.622
https://doi.org/10.1200/jco.2019.37.4_suppl.622
Autor:
Mercedes Salgado Fernández, Antia Cousillas, Elena Brozos Vazquez, Mónica Jorge Fernández, Maria Luz Pellon Augusto, Begoña Graña, Ana Montes, Yolanda Vidal Insua, Paula Gonzalez Villarroel, Carlos Romero Reinoso, Marta Carmona Campos, Jose Carlos Mendez, Juan De la camara, Francisca Vázquez Rivera, Guillermo Alfonso Quintero Aldana, Sonia Candamio Folgar, Elena Gallardo Martin, Nieves Martinez Lago, Marta Covela Rúa, Margarita Reboredo Lopez
Publikováno v:
Journal of Clinical Oncology. 36:e15561-e15561
e15561Background: BRAF mutations, mostly missense V600E, occur in approximately 8% to 12% of patients with metastatic colorectal cancer (mCRC). BRAF (V600E) mt is a strong predictor of a poor progn...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e48e4b5a359b686863703bd0f12ecb3e
https://doi.org/10.1200/jco.2018.36.15_suppl.e15561
https://doi.org/10.1200/jco.2018.36.15_suppl.e15561
Autor:
Alexandra Sabela Cortegoso mosquera, Sonia Candamio Folgar, Rafael López, Luis Leon Mateos, Maria Vieito, C. Lopez, Urbano Anido Herranz, Marta Carmona Campos, Elena Brozos Vazquez, Rafael Varela Ponte, Santiago Aguin Losada, Nieves Martinez Lago
Publikováno v:
Journal of Clinical Oncology. 31:e16095-e16095
e16095 Background: CRPC remains a therapeutic challenge, although in recent years the introduction of new agents has allowed an improvement in overall survival of these patients. In the literature there are few data on the use of cyclophosphamide in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b22cf937ec392617b1d8018b7c43f4fd
https://doi.org/10.1200/jco.2013.31.15_suppl.e16095
https://doi.org/10.1200/jco.2013.31.15_suppl.e16095
Autor:
Marta Carmona Campos, Sonia Candamio, Rafael López, Isabel Galrisa Neto, Francisco Baron, Maria Vieito, C. Lopez, Nieves Martinez Lago
Publikováno v:
Journal of Clinical Oncology. 31:e20708-e20708
e20708 Background: Malignant bowel obstruction is a complex syndrome that needs a multidisciplinary management and a better definition of prognostic risk factors. Methods: Information of patients with known history of cancer, admitted for a first epi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec75ba82068b7f5c4d23cf0571e01388
https://doi.org/10.1200/jco.2013.31.15_suppl.e20708
https://doi.org/10.1200/jco.2013.31.15_suppl.e20708